アクセス数 : ?
ダウンロード数 : ?
ID 116083
著者
板東, 浩 Tokushima University|Kanaiso Hospital KAKEN研究者をさがす
Kato, Yoshinobu Kanaiso Hospital
Kato, Yoshikane Kanaiso Hospital
Matsuzaki, Sayuri Kanaiso Hospital
Waka, Shinnichi Kanaiso Hospital
Ogura, Katsunori Kanaiso Hospital
キーワード
Xultophy
Degludec and Liraglutide
Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist
Dual Action of Liraglutide and Insulin Degludec
European Xultophy Treatment Retrospective Audit
資料タイプ
学術雑誌論文
抄録
The patient is a 56-year old (yo) female with type 2 diabetes mellitus (T2DM). Medical histories include persisting T2DM from 35yo, renal stone at 43yo, hypertension from 45yo, photocoagulation for retinopathy on 54yo. An incidentaloma was found in the left adrenal gland, where endocrinological exams were negative for functional tumor. Her diabetic control situation became worse with HbA1c > 10%, then the treatment has been changed from multiple daily injection (MDI), Dulaglutide to Xultophy which is combined agents of degludec and liraglutide (IDegLira). It was provided 10-18 doses daily, and then glucose variability profile was improved satisfactory, suggesting the dual synergistic effects.
掲載誌名
Asploro Journal of Biomedical and Clinical Case Reports
ISSN
25820370
出版者
Asploro
4
1
開始ページ
77
終了ページ
83
発行日
2021-04-06
権利情報
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系